Trial
NCT02281838
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alberta
Collaborators
—
Condition
Intracerebral Hemorrhage
Intervention
labetalol/hydralazine/enalapril
Why stopped
Slow enrolment after publication of the Interact III study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-06